[1]
L. Wu and M. Jin, “Clinical Significance of Serum MMP-9, S100-β and GFAP in Patients with Mental Disorders after Traumatic Brain Injury”, Actas Esp Psiquiatr, vol. 53, no. 1, pp. 11–18, Jan. 2025.